Literature DB >> 27002121

Invasive coronary imaging: any role in primary and secondary prevention?

Carlo Di Mario1, Pedro R Moreno2.   

Abstract

This review discusses the possibilities offered by new modalities of non-invasive and invasive coronary imaging in an effort to optimize risk stratification for coronary artery disease, and identify subgroups at high risk that may benefit from an aggressive, personalized approach, with access to a growing number of novel drugs and interventions. Special emphasis is placed on the progress of novel invasive imaging techniques such as near infrared spectroscopy and optical coherence tomography that can reliably identify thin-capped fibroatheromas. Multiple trials are exploring the feasibility of these techniques to guide modulation of risk factor control and treatment of non-flow limiting lesions at high risk of destabilization and progression in patients undergoing clinically mandated angioplasty of angiographically critical lesions. Asymptomatic patients at high risk of cardiovascular ischaemic events may also benefit, with the intermediate step of a wider application of calcium score and angiography with multi-slice computed tomography, by a selective use of invasive imaging. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Coronary atherosclerosis; Coronary multi-slice computed tomography; Intravascular ultrasound; Near infrared spectroscopy; Optical coherence tomography

Mesh:

Year:  2016        PMID: 27002121      PMCID: PMC4917744          DOI: 10.1093/eurheartj/ehv323

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  35 in total

1.  The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).

Authors:  Cihan Simsek; Hector M Garcia-Garcia; Robert-Jan van Geuns; Michael Magro; Chrysafios Girasis; Nicolas van Mieghem; Mattie Lenzen; Sanneke de Boer; Evelyn Regar; Willem van der Giessen; Joel Raichlen; Henricus J Duckers; Felix Zijlstra; Ton van der Steen; Eric Boersma; Patrick W Serruys
Journal:  EuroIntervention       Date:  2012-06-20       Impact factor: 6.534

2.  Epilogue: what do clinicians expect from imagers?

Authors:  Eugene Braunwald
Journal:  J Am Coll Cardiol       Date:  2006-04-18       Impact factor: 24.094

3.  2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

Authors:  Gilles Montalescot; Udo Sechtem; Stephan Achenbach; Felicita Andreotti; Chris Arden; Andrzej Budaj; Raffaele Bugiardini; Filippo Crea; Thomas Cuisset; Carlo Di Mario; J Rafael Ferreira; Bernard J Gersh; Anselm K Gitt; Jean-Sebastien Hulot; Nikolaus Marx; Lionel H Opie; Matthias Pfisterer; Eva Prescott; Frank Ruschitzka; Manel Sabaté; Roxy Senior; David Paul Taggart; Ernst E van der Wall; Christiaan J M Vrints; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Juhani Knuuti; Marco Valgimigli; Héctor Bueno; Marc J Claeys; Norbert Donner-Banzhoff; Cetin Erol; Herbert Frank; Christian Funck-Brentano; Oliver Gaemperli; José R Gonzalez-Juanatey; Michalis Hamilos; David Hasdai; Steen Husted; Stefan K James; Kari Kervinen; Philippe Kolh; Steen Dalby Kristensen; Patrizio Lancellotti; Aldo Pietro Maggioni; Massimo F Piepoli; Axel R Pries; Francesco Romeo; Lars Rydén; Maarten L Simoons; Per Anton Sirnes; Ph Gabriel Steg; Adam Timmis; William Wijns; Stephan Windecker; Aylin Yildirir; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2013-08-30       Impact factor: 29.983

4.  Non-adherence to cardiovascular medications.

Authors:  Kumaran Kolandaivelu; Benjamin B Leiden; Patrick T O'Gara; Deepak L Bhatt
Journal:  Eur Heart J       Date:  2014-09-28       Impact factor: 29.983

5.  NIRS and IVUS for characterization of atherosclerosis in patients undergoing coronary angiography.

Authors:  Salvatore Brugaletta; Hector M Garcia-Garcia; Patrick W Serruys; Sanneke de Boer; Jurgen Ligthart; Josep Gomez-Lara; Karen Witberg; Roberto Diletti; Joanna Wykrzykowska; Robert-Jan van Geuns; Carl Schultz; Evelyn Regar; Henricus J Duckers; Nicolas van Mieghem; Peter de Jaegere; Sean P Madden; James E Muller; Antonius F W van der Steen; Wim J van der Giessen; Eric Boersma
Journal:  JACC Cardiovasc Imaging       Date:  2011-06

6.  Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

Authors:  Jean-Claude Tardif; Jean Grégoire; Philippe L L'Allier; Reda Ibrahim; Jacques Lespérance; Therese M Heinonen; Simon Kouz; Colin Berry; Russell Basser; Marc-André Lavoie; Marie-Claude Guertin; Josep Rodés-Cabau
Journal:  JAMA       Date:  2007-03-26       Impact factor: 56.272

7.  In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography.

Authors:  Haibo Jia; Farhad Abtahian; Aaron D Aguirre; Stephen Lee; Stanley Chia; Harry Lowe; Koji Kato; Taishi Yonetsu; Rocco Vergallo; Sining Hu; Jinwei Tian; Hang Lee; Seung-Jung Park; Yang-Soo Jang; Owen C Raffel; Kyoichi Mizuno; Shiro Uemura; Tomonori Itoh; Tsunekazu Kakuta; So-Yeon Choi; Harold L Dauerman; Abhiram Prasad; Catalin Toma; Iris McNulty; Shaosong Zhang; Bo Yu; Valentine Fuster; Jagat Narula; Renu Virmani; Ik-Kyung Jang
Journal:  J Am Coll Cardiol       Date:  2013-06-27       Impact factor: 24.094

8.  Randomized trial of preventive angioplasty in myocardial infarction.

Authors:  David S Wald; Joan K Morris; Nicholas J Wald; Alexander J Chase; Richard J Edwards; Liam O Hughes; Colin Berry; Keith G Oldroyd
Journal:  N Engl J Med       Date:  2013-09-01       Impact factor: 91.245

9.  Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial.

Authors:  Jean-Claude Tardif; Christie M Ballantyne; Philip Barter; Jean-Louis Dasseux; Zahi A Fayad; Marie-Claude Guertin; John J P Kastelein; Constance Keyserling; Heather Klepp; Wolfgang Koenig; Philippe L L'Allier; Jacques Lespérance; Thomas F Lüscher; John F Paolini; Ahmed Tawakol; David D Waters
Journal:  Eur Heart J       Date:  2014-04-29       Impact factor: 29.983

10.  Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.

Authors:  Anthony H Gershlick; Jamal Nasir Khan; Damian J Kelly; John P Greenwood; Thiagarajah Sasikaran; Nick Curzen; Daniel J Blackman; Miles Dalby; Kathryn L Fairbrother; Winston Banya; Duolao Wang; Marcus Flather; Simon L Hetherington; Andrew D Kelion; Suneel Talwar; Mark Gunning; Roger Hall; Howard Swanton; Gerry P McCann
Journal:  J Am Coll Cardiol       Date:  2015-03-17       Impact factor: 24.094

View more
  2 in total

1.  SYNTAX score-0 patients: risk stratification in nonobstructive coronary artery disease.

Authors:  Christoph Sinning; Elvin Zengin; Christoph Waldeyer; Moritz Seiffert; Renate B Schnabel; Edith Lubos; Tanja Zeller; Christoph Bickel; Stefan Blankenberg; Peter M Clemmensen; Dirk Westermann
Journal:  Clin Res Cardiol       Date:  2016-06-30       Impact factor: 5.460

Review 2.  Intra-coronary Imaging for the Evaluation of Plaque Modifications Induced by Drug Therapies for Secondary Prevention.

Authors:  Ismail Dogu Kilic; Enrico Fabris; Elvin Kedhi; Liviu-Nicolae Ghilencea; Gianluca Caiazzo; Sara Abou Sherif; Carlo Di Mario
Journal:  Curr Atheroscler Rep       Date:  2020-10-06       Impact factor: 5.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.